Similar articles

• Regression of pulmonary lymphangioleiomyomatosis (PLAM)-associated retroperitoneal angiomyolipoma post-lung transplantation with rapamycin treatment.

  Morton JM, McLean C, Booth SS, Snell GI, Whitford HM. Morton JM, et al. J Heart Lung Transplant. 2008 Apr;27(4):462-5. doi: 10.1016/j.healun.2008.01.005. J Heart Lung Transplant. 2008. PMID: 18374885
• Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation.

  Chen F, Omasa M, Kondo N, Fujinaga T, Shoji T, Sakai H, Bando T. Chen F, et al. Ann Thorac Surg. 2009 Jan;87(1):e6-7. doi: 10.1016/j.athoracsur.2008.07.107. Ann Thorac Surg. 2009. PMID: 19101258
• Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis.

  Ohara T, Oto T, Miyoshi K, Tao H, Yamane M, Toyooka S, Okazaki M, Date H, Sano Y. Ohara T, et al. Ann Thorac Surg. 2008 Dec;86(6):e7-8. doi: 10.1016/j.athoracsur.2008.07.062. Ann Thorac Surg. 2008. PMID: 19021963
• Current management of lymphangioleiomyomatosis.

  Taillé C, Borie R, Crestani B. Taillé C, et al. Curr Opin Pulm Med. 2011 Sep;17(5):374-8. doi: 10.1097/MCP.0b013e328349ac8c. Curr Opin Pulm Med. 2011. PMID: 21760507 Review.
• Chylothoraces after lung transplantation for lymphangioleiomyomatosis: review of the literature and utilization of a pleurovenous shunt.

  Fremont RD, Milstone AP, Light RW, Ninan M. Fremont RD, et al. J Heart Lung Transplant. 2007 Sep;26(9):953-5. doi: 10.1016/j.healun.2007.07.008. J Heart Lung Transplant. 2007. PMID: 17845935 Review.